The aromatase inhibitors in early breast cancer: who, when, and why?
Author:
Affiliation:
1. Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, NSW.
Publisher
AMPCo
Subject
General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.2005.tb06882.x
Reference29 articles.
1. Sources of estrogen and their importance
2. Aromatase Inhibition for Breast Cancer Treatment
3. An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane
4. Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dual-target inhibitors based on ERα: Novel therapeutic approaches for endocrine resistant breast cancer;European Journal of Medicinal Chemistry;2024-04
2. Whole Body Vibration Exposure on Markers of Bone Turnover, Body Composition, and Physical Functioning in Breast Cancer Patients Receiving Aromatase Inhibitor Therapy: A Randomized Controlled Trial;Integrative Cancer Therapies;2018-06-28
3. Aromatase inhibitors in the breast cancer clinic: focus on exemestane;Endocrine-Related Cancer;2014-02
4. Age effects on survival from early breast cancer in clinical settings in Australia;ANZ Journal of Surgery;2012-07
5. Verschreibungsverhalten von Aromataseinhibitoren in der adjuvanten endokrinen Therapie des Mammakarzinoms – eine aktuelle Bestandsaufnahme unter Meinungsbildnern in Deutschland;Geburtshilfe und Frauenheilkunde;2009-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3